A detailed history of Accuvest Global Advisors transactions in Johnson & Johnson stock. As of the latest transaction made, Accuvest Global Advisors holds 2,974 shares of JNJ stock, worth $433,757. This represents 0.43% of its overall portfolio holdings.

Number of Shares
2,974
Holding current value
$433,757
% of portfolio
0.43%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$145.48 - $167.38 $432,657 - $497,788
2,974 New
2,974 $481,000
Q1 2024

May 14, 2024

SELL
$155.22 - $162.74 $98,875 - $103,665
-637 Reduced 17.49%
3,006 $475,000
Q4 2023

Feb 13, 2024

SELL
$145.6 - $158.88 $144,435 - $157,608
-992 Reduced 21.4%
3,643 $571,000
Q3 2023

Nov 13, 2023

SELL
$155.75 - $174.48 $190,793 - $213,738
-1,225 Reduced 20.9%
4,635 $721,000
Q2 2023

Aug 11, 2023

SELL
$154.35 - $166.11 $3,704 - $3,986
-24 Reduced 0.41%
5,860 $969,000
Q1 2023

May 12, 2023

SELL
$151.05 - $180.26 $701,476 - $837,127
-4,644 Reduced 44.11%
5,884 $912,000
Q4 2022

Jan 12, 2023

BUY
$160.2 - $179.79 $837,365 - $939,762
5,227 Added 98.6%
10,528 $0
Q3 2022

Oct 20, 2022

BUY
$161.33 - $179.52 $67,435 - $75,039
418 Added 8.56%
5,301 $866,000
Q2 2022

Aug 12, 2022

SELL
$168.19 - $186.01 $564,782 - $624,621
-3,358 Reduced 40.75%
4,883 $867,000
Q1 2022

May 06, 2022

BUY
$158.14 - $179.59 $184,707 - $209,761
1,168 Added 16.51%
8,241 $1.46 Million
Q4 2021

Jan 28, 2022

BUY
$155.93 - $173.01 $228,437 - $253,459
1,465 Added 26.12%
7,073 $1.21 Million
Q3 2021

Nov 03, 2021

SELL
$161.5 - $179.47 $98,192 - $109,117
-608 Reduced 9.78%
5,608 $920,000
Q2 2021

Aug 16, 2021

BUY
$159.48 - $171.07 $991,327 - $1.06 Million
6,216 New
6,216 $1.02 Million
Q1 2021

Aug 16, 2021

SELL
$153.07 - $170.48 $339,203 - $377,783
-2,216 Closed
0 $0
Q3 2020

Oct 30, 2020

SELL
$140.38 - $153.83 $439,950 - $482,103
-3,134 Reduced 58.58%
2,216 $330,000
Q2 2020

Jul 15, 2020

SELL
$128.81 - $155.51 $38,385 - $46,341
-298 Reduced 5.28%
5,350 $752,000
Q1 2020

Apr 23, 2020

BUY
$111.14 - $153.99 $627,718 - $869,735
5,648 New
5,648 $741,000
Q1 2019

Apr 30, 2019

SELL
$125.72 - $139.79 $1.28 Million - $1.43 Million
-10,194 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$122.84 - $147.84 $307,468 - $370,043
2,503 Added 32.54%
10,194 $1.32 Million
Q3 2018

Oct 31, 2018

BUY
$121.58 - $142.88 $935,071 - $1.1 Million
7,691 New
7,691 $1.06 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $381B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Accuvest Global Advisors Portfolio

Follow Accuvest Global Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Accuvest Global Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Accuvest Global Advisors with notifications on news.